David P. Meeker's most recent trade in Rhythm Pharmaceuticals Inc. was a trade of 107,850 Stock Options (Right to Buy) done . Disclosure was reported to the exchange on Feb. 11, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Rhythm Pharma Inc | David P. Meeker | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2026 | 107,850 | 107,850 | - | - | Stock Options (Right to Buy) | |
| Rhythm Pharma Inc | David P. Meeker | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2026 | 71,900 | 71,900 | - | - | Restricted Stock Units | |
| Rhythm Pharma Inc | David P. Meeker | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2026 | 68,713 | 270,538 (0%) | 0% | - | Common Stock | |
| Rhythm Pharma Inc | David P. Meeker | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2026 | 33,338 | 100,012 | - | - | Restricted Stock Units | |
| Rhythm Pharma Inc | David P. Meeker | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 108.99 per share. | 01 Feb 2026 | 31,522 | 239,016 (0%) | 0% | 109.0 | 3,435,583 | Common Stock |
| Rhythm Pharma Inc | David P. Meeker | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2026 | 21,250 | 42,500 | - | - | Restricted Stock Units | |
| Rhythm Pharma Inc | David P. Meeker | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2026 | 14,125 | 14,125 | - | - | Restricted Stock Units | |
| Trevi Therapeutics Inc | David P. Meeker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 45,000 | 45,000 | - | - | Nonstatutory Stock Option (right to buy) | |
| Rhythm Pharma Inc | David P. Meeker | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2025 | 43,620 | 0 | - | - | Stock Option (Right to Buy) | |
| Rhythm Pharma Inc | David P. Meeker | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.59 per share. | 03 Jun 2025 | 43,620 | 245,445 (0%) | 0% | 4.6 | 200,216 | Common Stock |
| Rhythm Pharma Inc | David P. Meeker | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 65.04 per share. | 03 Jun 2025 | 43,346 | 202,099 (0%) | 0% | 65.0 | 2,819,358 | Common Stock |
| Rhythm Pharma Inc | David P. Meeker | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 65.60 per share. | 03 Jun 2025 | 274 | 201,825 (0%) | 0% | 65.6 | 17,975 | Common Stock |
| Rhythm Pharma Inc | David P. Meeker | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2025 | 200,000 | 200,000 | - | - | Stock Options (Right to Buy) | |
| Rhythm Pharma Inc | David P. Meeker | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2025 | 133,350 | 133,350 | - | - | Restricted Stock Units | |
| Rhythm Pharma Inc | David P. Meeker | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2025 | 21,250 | 63,750 | - | - | Restricted Stock Units | |
| Rhythm Pharma Inc | David P. Meeker | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2025 | 21,250 | 211,177 (0%) | 0% | - | Common Stock | |
| Rhythm Pharma Inc | David P. Meeker | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 57.22 per share. | 14 Feb 2025 | 9,896 | 201,281 (0%) | 0% | 57.2 | 566,249 | Common Stock |
| Rhythm Pharma Inc | David P. Meeker | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2025 | 14,125 | 194,205 (0%) | 0% | - | Common Stock | |
| Rhythm Pharma Inc | David P. Meeker | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2025 | 14,125 | 28,250 | - | - | Restricted Stock Units | |
| Rhythm Pharma Inc | David P. Meeker | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 59.43 per share. | 01 Feb 2025 | 4,278 | 189,927 (0%) | 0% | 59.4 | 254,242 | Common Stock |
| Trevi Therapeutics Inc | David P. Meeker | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.43 per share. | 27 Aug 2024 | 4,555 | 357,044 (2%) | 0% | 1.4 | 6,514 | Common Stock |
| Trevi Therapeutics Inc | David P. Meeker | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Aug 2024 | 4,555 | 0 | - | - | Stock Option (right to buy) | |
| Trevi Therapeutics Inc | David P. Meeker | Director | Sale of securities on an exchange or to another person at price $ 2.93 per share. | 27 Aug 2024 | 4,555 | 352,489 (1%) | 0% | 2.9 | 13,353 | Common Stock |
| Trevi Therapeutics Inc | David P. Meeker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 30,000 | 30,000 | - | - | Nonstatutory Stock Option (right to buy) | |
| Rhythm Pharma Inc | David P. Meeker | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 39.22 per share. | 19 Mar 2024 | 45,494 | 174,605 (0%) | 0% | 39.2 | 1,784,275 | Common Stock |
| Rhythm Pharma Inc | David Meeker P. | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2024 | 259,000 | 259,000 | - | - | Stock Option (Right to Buy) | |
| Rhythm Pharma Inc | P. David Meeker | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2024 | 99,000 | 220,099 (0%) | 0% | 0 | Common Stock | |
| Rhythm Pharma Inc | Meeker David P. | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2024 | 85,000 | 85,000 | - | - | Restricted Stock Units | |
| Rhythm Pharma Inc | Meeker David P. | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2024 | 14,125 | 42,375 | - | - | Restricted Stock Units | |
| Rhythm Pharma Inc | P. David Meeker | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2024 | 14,125 | 125,460 (0%) | 0% | - | Common Stock | |
| Rhythm Pharma Inc | David P. Meeker | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 45.06 per share. | 01 Feb 2024 | 4,361 | 121,099 (0%) | 0% | 45.1 | 196,507 | Common Stock |
| Trevi Therapeutics Inc | David P. Meeker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2023 | 30,000 | 30,000 | - | - | Nonstatutory Stock Option (right to buy) | |
| Rhythm Pharma Inc | David P. Meeker | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 229,600 | 229,600 | - | - | Stock Option (Right to Buy) | |
| Rhythm Pharma Inc | David P. Meeker | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 56,500 | 56,500 | - | - | Restricted Stock Units | |
| Trevi Therapeutics Inc | David P. Meeker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2022 | 20,000 | 20,000 | - | - | Nonstatutory Stock Option (right to buy) | |
| Trevi Therapeutics Inc | David P. Meeker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2021 | 20,000 | 20,000 | - | - | Nonstatutory Stock Option (right to buy) | |
| Rhythm Pharma Inc | David P. Meeker | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 20.17 per share. | 30 Mar 2021 | 10,000 | 111,335 (0%) | 0% | 20.2 | 201,713 | Common Stock |